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Changes in prolactin secretion 
in the short- and long-term 
after adrenalectomy
Efeito da evolução temporal da adrenalectomia 
na secreção de prolactina
Maria Thereza C. Laguna-Abreu1, Carla Germano2, Ayrton C. Moreira2, 
José Antunes-Rodrigues3, Lucila Elias3, Margaret Castro2
ABSTRACT
Objective: To evaluate the modulation of the hypothalamus-pituitary-adrenal axis (HPA) on 
prolactin secretion in rats after adrenalectomy (ADX). Materials and methods: Plasma corti-
costerone, ACTH, and prolactin concentrations were measured by radioimmunoassay in rats 
after bilateral ADX in the short- (3 hours and 1day) and long-term (3, 7, and 14 days). Results: 
Animals that underwent ADX showed undetectable corticosterone levels and a triphasic ACTH 
response with a transient increase (3h), a decrease (1d), and further increase in the long-term 
after ADX. Sham animals showed a marked increase in corticosterone and ACTH levels three 
hours after surgery, with a decrease to basal levels thereafter. Plasma prolactin levels were not 
changed after ADX. Conclusion: There are different points of equilibrium in the HPA axis after 
the glucocorticoid negative feedback is removed. Prolactin plasma secretion is not altered in the 
short or long- term after ADX, suggesting that the peptidergic neurons essential for prolactin 
release are not activated after ADX. Arq Bras Endocrinol Metab. 2012;56(4):244-9
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ReSUMO
Objetivo: Avaliar a modulação do eixo hipotálamo-hipófise-adrenal (HHA) sobre a secreção de 
prolactina após adrenalectomia (ADX). Materiais e métodos: Quantificamos por RIE corticoste-
rona, ACTH e prolactina plasmáticos em ratos após curtos (3 horas e 1 dia) e longos (3, 7 e 14 
dias) períodos de ADX bilateral. Resultados: Animais ADX mostraram níveis indetectáveis  de 
corticosterona. As concentrações plasmáticas de ACTH apresentaram resposta trifásica: aumento 
transitório (3h), diminuição (1d) e novo aumento após longos períodos de ADX. Animais Sham 
mostraram aumento de corticosterona/ACTH após três horas de cirurgia, diminuindo posterior-
mente aos níveis basais. As concentrações plasmáticas de prolactina não se alteraram após ADX. 
Conclusão: Existem diferentes pontos de equilíbrio do eixo HHA após a remoção da retroali-
mentação negativa exercida pelos glicocorticoides. A secreção de prolactina não se alterou após 
curtos/longos períodos de ADX, sugerindo que os neurônios peptidérgicos essenciais para a li-
beração de prolactina não estão ativados durante os diferentes períodos de ADX. Arq Bras Endocrinol 
Metab. 2012;56(4):244-9
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INTRODUCTION
Prolactin is a polypeptide hormone synthesized and secreted from specialized cells of the anterior pitui­
tary gland, called lactotrophs. In humans, an alternative 
promoter can drive the expression of this hormone also 
in extra­pituitary sites. Besides its biological actions in 
the uterus and mammary gland, an important role of 
prolactin has been well established in the modulation 
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of the immune system activity, and in the maintenance 
of the internal environment by regulation of osmotic 
balan ce in some species (1,2). More recently, circulat­
ing and locally­produced PRL has also been implicated 
as risk factors for cancer development (3,4).
Although hypothalamic dopamine provides inhi­
bitory control over prolactin synthesis and secretion, 
other factors produced in the brain, pituitary gland, 
and peripheral organs have also been shown to inhibit 
or stimulate prolactin secretion. In addition, prolactin 
itself can act on the hypothalamus to regulate its own 
secretion by means of a feedback mechanism (1,2). 
Prolactin­releasing stimuli not only include nursing, 
but also light, noise, smells, and stress (2,5). Prolactin 
secretory response differs depending on the stress sti­
mulus, such as ether (6,7), restraint (6,8­12), thermal 
stress (13), hemorrhage (9), social conflict (14), and 
even academic stress in humans (15). 
Prolactin immunoreactivity is found in numerous 
hypothalamic areas in a variety of mammals. In the rat 
hypothalamus, prolactin immunoreactivity is detectable 
in the dorsomedial, ventromedial, supraoptic, and pa­
raventricular (16,17) nuclei. Vasopressin and oxytocin 
are synthesized in the magnocellular neurons located 
mainly in the posterior division of the paraventricular 
and supraoptic nuclei, and may be involved in the re­
gulation of prolactin secretion (18,19). Previous stu­
dies have clearly indicated that disturbance in water and 
electrolyte regulation alters adenohypophysial prolactin 
secretion (20). We have previously studied the effect 
of acute extracellular volume expansion by intravenous 
injection of isotonic or hypertonic saline on the secre­
tion of prolactin, corticosterone, vasopressin, oxytocin, 
and atrial natriuretic peptide. We demonstrated that 
the increment in prolactin and oxytocin was blocked 
by the inhibition of the hypothalamus­pituitary­adrenal 
(HPA) axis by dexamethasone (21). Therefore, pro­
lactin and oxytocin responses induced by isotonic or 
hypertonic extracellular volume expansion are likely to 
be modulated by the HPA axis. 
HPA axis is regulated by circadian rhythm, stress­
ful stimuli, and glucocorticoid negative feedback. Hy­
pothalamic­pituitary activity is dramatically enhanced 
after adrenalectomy (ADX), which causes changes in 
pituitary corticotrophs, and might play a role in prolac­
tin response after stress (22­24). Therefore, in the pre­
sent study, we evaluated the modulation of HPA axis 
on plasma prolactin secretion in rats in the short­ and 
long­term after ADX.
MATeRIAlS AND MeTHODS
Animals and experimental design 
Adult male Wistar rats weighing 200 g were housed in 
individual cages (30 x 19 x 13 cm), in a room provided 
with temperature (23 ± 1ºC) and light control (12h light 
– 12h dark cycle) with free access to pelleted food and 
tap water. All experimental protocols were performed 
according to the guidelines of the Ethics Committee for 
Animal Use of the School of Medicine of Ribeirao Preto, 
Universidade de Sao Paulo (protocol no. 056/2005). 
Bilateral ADX and Sham surgery were performed under 
ether anesthesia using the dorsal approach. ADX rats re­
ceived oral saline (0.9% NaCl) ad libitum. Animals were 
studied in basal condition at different times (3h, and 1, 
3, 7, and 14 days) after Sham surgery or ADX. Animals 
were killed by decapitation between 8:30 and 10:30 a.m. 
Blood was collected from the trunk into heparinized 
plastic tubes, and centrifuged at 4ºC. Plasma samples 
were frozen at ­20ºC until ACTH, corticosterone (B), 
and prolactin (PRL) determinations.
Assays and methods
Plasma corticosterone and ACTH were determined by 
radioimmunoassay (RIA), after plasma extraction using 
ethanol or silicic acid, respectively (25). Plasma PRL 
was determined using the NIDDK RIA reagents, and 
expressed in terms of RP­1 reference preparations (26). 
Mean assay sensitivity was 0.4 µg/dL for corticostero­
ne, 7.7 pg/mL for ACTH, and 0.4 ng/mL for PRL. 
The intra­ and inter­assay coefficients of variation (CV) 
were 4.8% and 6.7% for corticosterone, 6.3% and 14.0% 
for ACTH, and 11.7% and 5% for PRL. All samples 
were analyzed in duplicate.
Statistical analysis
Data are expressed as means ± SEM. Data were compa­
red using the Mann­Whitney test or analysis of variance 
(Kruskal­Wallis test and Dunn’s post­test). Significance 
was set at p < 0.05.
ReSUlTS
Corticosterone concentration
There was a significant increase in plasma corticoste­
rone levels 3h after Sham surgery compared with 1, 3, 
7, and 14 days (p < 0.05), with no difference in plas­
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ma corticosterone levels between 1, 3, 7, and 14 days 
(Figure 1A). Sham groups showed higher corticostero­
ne levels than ADX groups throughout the study (p < 
0.004). ADX groups showed undetectable corticoste­
rone levels at all periods studied.
ACTH concentration
ACTH plasma levels after 3h, 1 and 3 days of Sham sur­
gery were similar, and all of them were higher than tho­
se observed after 7 and 14 days (p < 0.05; Figure 1B). 
Plasma ACTH showed a triphasic response to bilateral 
ADX, with a transient increase after 3h (p < 0.0001), 
followed by a decrease after 1 day (p < 0.0001), and a 
further increase after 3, 7, and 14 days (p < 0.001). Plas­
ma ACTH levels were higher in ADX groups compared 
with the Sham group in all periods studied (p < 0.008).
Prolactin (PRl) concentration
The Sham group did not show difference in PRL le­
vels after 3 hours (2.8 ± 0.9), 1d (5.9 ± 3.2 ng/mL), 
3d (3.8 ± 1.7 ng/mL), 7d (4.3 ± 2.9 ng/mL), and 
14d (3.2 ± 1.6 ng/mL). The same was also observed in 
plasma PRL levels in ADX rats after 3h (4.9 ± 4.1 ng/
mL), 1d (5.3 ± 2.3 ng/mL), 3d (3.9 ± 1.9 ng/mL), 
7d (5.2 ± 3.5 ng/mL), and 14 days (3.3 ± 1.9 ng/mL) 
(Figure 1C). No difference was observed between ADX 
and Sham groups at the same moment, at all time­
­points of the study.
DISCUSSION
The hypothalamic paraventricular nucleus (PVN) has 
been shown to be important for PRL secretion, and 
may play a role in the suppression of tuberoinfundi­
bular dopamine neurons (27,28). Furthermore, the 
presence of CRH receptors have been demonstrated in 
dopamine neurons, suggesting a possible role of CRH 
in the regulation of PRL secretion (29). Stress media­
tors – CRH and vasopressin – are essential not only for 
ACTH release in response to stress, but also in ACTH 
release after ADX. Therefore, we hypothesized that 
prolactin secretion could be affected in the short­ and 
long­term after ADX. In the present study, we obser­
ved no changes in plasma prolactin concentrations in 
the short­ and long­term after ADX. As expected, these 
animals showed undetectable corticosterone levels, and 
the classic ACTH triphasic response to the removal of 
glucocorticoid feedback.
ADX is an interesting experimental model, since it 
alters CRH/vasopressin expression in the PVN, indu­
ces hydroeletrolytic imbalance, and represents a stress 
model that may modulate PRL secretion. Our data de­
monstrated a triphasic response pattern of ACTH levels 
induced by ADX: at first, there was a marked increase in 
ACTH release, leading to depletion of pituitary ACTH 
storage, which explains the decrease in circulating 
ACTH levels during the second phase. Finally, com­
pensatory changes occur, the most important being an 
increase in ACTH synthesis, as confirmed by increased 
pituitary ACTH content and pro­opiomelanocortin 
mRNA expression (19,24,25). These findings indicate 
a profound alteration in the HPA axis induced by ADX 
in the short­ and long­term.
Different stress models might determine the role 
of hypothalamic factors in ACTH and/or prolactin 
responses. Previous data have demonstrated increased 
serum PRL stimulated by ether stress, with maximum 
effect one minute after the onset of stress (30). In addi­
tion, reports have shown that ADX potentiates prolac­
tin release in response to ether stress (31); this incre­
ment usually occurs after 5 to 10 minutes, and remains 
significantly higher until 30 min after stress compared 
with controls (32). In the present study, prolactin levels 
did not differ between intact animals and those in the 
short­term after ADX (3 hours). However, as mentio­
ned, physiological responses to ether stress are usually 
observed within few minutes (30,31). In this context, 
the lack of PRL response 3 hours after ADX may not 
reflect PRL immediate response. In addition, we can­
not rule out that, in our model, PRL levels had already 
returned to basal levels. Previously, our group descri­
bed an increase in OT concentration 3 hours after ADX 
(19,24,25). It is important to point out that subcuta­
neous administration of oxytocin induces a reduction 
in basal, as well as in stress­induced prolactin secretion, 
in male rats (33­35). Therefore, increased OT levels 
observed at this moment could also compensate the ex­
pected increase of prolactin plasma secretion after ether 
and surgical stress (18).
We also demonstrated that prolactin plasma levels 
did not change in the long­term after removal of the 
glucocorticoid negative feedback, suggesting that ba­
sal prolactin secretion is not modulated by long­term 
ADX or by glucocorticoids. However, we cannot rule 
out the effect of plasma hypoosmolality observed in the 
long­term after ADX. Indeed, we previously reported 
a significant decrease in plasma osmolality associated 
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# p < 0.01 (ADX vs. intact group), * p < 0.008 (Sham vs. ADX); + p < 0.0001 (ADX 1D vs. ADX 3H, 3D, 7D, and 14D); p < 0.0001 (ADX 3H vs. ADX 3D, 7D, and 14D).
Figure 1. Plasma corticosterone (A), ACTH (B), and prolactin (C) levels in intact animals (I; hatched boxes), 3 hours (h); 1, 3, 7, and 14 days (d); after sham 
surgery (empty boxes) or adrenalectomy (ADX; filled boxes). The numbers of animals in each group varied from 5 to 25.
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with severe dehydration in rats that underwent ADX 
after 3, 7, and 14 days (24). Moreover, chronic hypoos­
molality inhibits PRL secretion induced by the stress of 
restraint, indicating the involvement of magnocellular 
AVP neurons in these responses (36). 
Although AVP induces prolactin release in vivo (37), 
we did not observe changes in plasma AVP throughout 
the time course after ADX surgery (24), suggesting 
that this peptide might not have a role in prolactin se­
cretion in this experimental model. We and others have 
shown an increase in plasma PRL induced by increased 
water and salt ingestion or after hypertonic EVE infu­
sion (21,38). However, the increase in PRL and OT 
levels after isotonic or hypertonic EVE were blocked 
by glucocorticoid treatment. These results are similar 
to those of a previous report that showed that gluco­
corticoids exert an inhibitory effect on parvocellular 
OT­expressing neurons (39), PRL and OT secretion 
induced by volume and concentration changes. 
Lesions in the PVN of rats strongly inhibited ether­
­induced ACTH secretion. In contrast, PVN lesion 
failed to inhibit ether­induced PRL release, suggesting 
that the peptidergic neurons essential for stress­induced 
PRL release are modulated by neurons other than PVN 
neurons (7). In addition, prolactin­releasing peptide 
(PrRP), expressed in the nucleus tractus solitarii and in 
the ventrolateral medulla oblongata, has been shown to 
induce prolactin secretion and plays an important role 
in the stress response (40).
 In conclusion, there are different HPA axis points of 
equilibrium after the glucocorticoid negative feedback 
is removed. Although prolactin is a hormone responsive 
to different stress factors, it does not seem to be altered 
in the short or long­term after ADX, suggesting that the 
peptidergic neurons essential for basal prolactin release 
are not activated during time course after ADX. 
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